Navigation Links
Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
Date:1/3/2012

CAMBRIDGE, Mass., Jan. 3, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) announced today that Idenix management will present a corporate overview at the 30th Annual J.P. Morgan Healthcare Conference on January 11, 2012 at 2:00 p.m. PST at the Westin St. Francis in San Francisco.  

The live and archived webcast of the company presentation can be accessed under "Calendar of Events" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com.

Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)

 


'/>"/>
SOURCE Idenix Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Idenix Pharmaceuticals Prices Public Offering of Common Stock
2. Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
3. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
4. Idenix to Host Conference Call Discussing Third Quarter and Nine Month 2011 Financial Results and Announces Presentations at the American Association for the Study of Liver Diseases Meeting (AASLD)
5. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
6. Idenix Pharmaceuticals to Present at an Upcoming Investor Conference
7. Idenix Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
8. Idenix Pharmaceuticals Reports First Quarter 2011 Financial Results
9. Idenix Pharmaceuticals Prices Public Offering of Common Stock
10. Idenix Pharmaceuticals Announces Proposed Public Offering of Common Stock
11. Idenix Announces Data Presentations at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Research and Markets has announced the addition of ... Markets and Companies" to their offering. ... , , ... The market value of drug delivery technologies and the anticancer drugs ... according to organs involved and the types of cancer as well ...
(Date:12/2/2016)... -- bioLytical Laboratories (das "Unternehmen"), ein Weltführer bei schnellen Tests ...  in einer Version mit geringeren Kosten einzuführen.  ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) Der ...
(Date:11/30/2016)... Research and Markets has announced the addition of the ... their offering. ... Detachable coil embolization is a minimally invasive method ... embolization treatment of cerebral aneurysms is less invasive and requires less recovery ... wall of an artery in the brain. This area bulges in the ...
Breaking Medicine Technology:
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... hot meals to needy individuals and families from eight different sites throughout Miami-Dade ... Thanksgiving Day. Over 1,000 volunteers worked very hard on Thanksgiving morning by putting ...
(Date:12/2/2016)... Miami, FL (PRWEB) , ... December 02, 2016 , ... ... they are winners of $1,000 each from the National Family Partnership and the Drug ... winning families who decorated their homes and the 10 winning schools who decorated their ...
(Date:11/30/2016)... ... November 30, 2016 , ... "I hate when the mixture ... brushing my teeth," said an inventor from Bridgewater, N.J. "I thought that there had ... handy device." , He developed the patent-pending DEFLECTOR to prevent saliva and toothpaste from ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... treatment has announced the opening of a new residential mental health treatment program ... mental health issues such as severe anxiety, depression, bi-polar disorder, and other related ...
(Date:11/30/2016)... ... November 30, 2016 , ... The Clinical Data Interchange ... FDA Binding Guidance goes into effect next month. Sponsors whose studies start after ... Data Standards Catalog. The current FDA Data Standards Catalog specifies the use of ...
Breaking Medicine News(10 mins):